Skip to main content Skip to main content
Institutional Filer · CIK 1601692

KOTLER KEVIN


PERIOD 2025-Q4 · SOURCE: SEC EDGAR (PUBLIC)

Holdings as of the 2025-Q4 13F-HR filing. 13F is disclosed up to 45 days after quarter-end.

34
Reported positions
$135M
Reported value
1
Quarters on file

What a 13F does — and does not — show

These figures come from Form 13F, a quarterly filing that large US institutional managers must submit to the SEC. It is a useful window, but a partial and lagged one, so read it carefully:

  • It is a snapshot, up to 45 days old. A 13F shows what a manager held on the last day of a quarter, filed up to 45 days later — the fund may have traded since.
  • Long US-listed stocks only. It excludes short positions, cash, bonds, most derivatives, and non-US or private holdings, so it is not the fund’s whole portfolio.
  • Reported 13F value is not assets under management. Every share and concentration figure below is a percentage of the reported 13F value only — not the firm’s total assets.
  • It describes, it does not recommend. A large or long-held position is not an endorsement, and none of this is investment advice.

Concentration

Share of the largest positions we rank. Long US-listed equity positions as filed; percentages are of reported 13F value, which excludes shorts, cash, non-US and private holdings.

TierReported valueShare
Top position$22M16.3%
Top 5$83M61.2%
Top 10$110M81.3%

Top holdings

#SecuritySharesReported value% of value
1ANGO ANGIODYNAMICS INC1,713,789$22M16.3%
2AUPH AURINIA PHARMACEUTICALS INC1,224,846$20M14.4%
3AVDL AVADEL PHARMACEUTICALS PLC741,343$16M11.8%
4OMER OMEROS CORP905,635$16M11.5%
5NPCE NEUROPACE INC631,468$10M7.2%
6MDWD MEDIWOUND LTD337,236$6M4.6%
7AXGN AXOGEN INC168,000$5M4.1%
8IART INTEGRA LIFESCIENCES HLDGS C427,445$5M3.9%
9ACRS ACLARIS THERAPEUTICS INC1,705,929$5M3.8%
10EVTL VERTICAL AEROSPACE LTD939,705$5M3.7%
11OSUR ORASURE TECHNOLOGIES INC1,801,446$4M3.2%
12LKFT GALAPAGOS NV90,000$3M2.2%

Sector mix

Reported 13F value by sector, as a share of the largest positions we rank. Sectors come from company reference data joined to each holding. 30% of this value is not classified to a sector and is excluded from the mix. Long US-listed equity positions as filed.

SectorReported valueShare
Healthcare$92M68.2%
Consumer Cyclical$2M1.5%

How this filer invests

Reproducible measures computed from the positions in this filer’s own 13F filings — not from any outside estimate.

How concentrated the book is

81%
Top 10 positions (of reported 13F value)
16%
Largest position
0.09
Concentration index (HHI, 0–1) — broadly diversified

Across 34 reported positions. Shares are of reported 13F value (long US-listed equity), which is not the firm’s total assets. The concentration index (HHI) is the sum of each position’s squared weight — higher means a book concentrated in fewer names.

Frequently asked

What does KOTLER KEVIN own?

KOTLER KEVIN reported 34 long US-listed equity positions worth $135M in its 2025-Q4 13F filing. The largest positions and their reported values are listed above.

What changed in KOTLER KEVIN's portfolio last quarter?

The quarter-over-quarter section lists new positions, exits, and the largest adds and trims versus the prior filing, measured on reported value.

Where does this data come from?

Holdings are parsed from SEC Form 13F-HR filings on EDGAR (public filings). 13F is disclosed up to 45 days after quarter-end and reflects long US-listed equity positions only. Informational, not investment advice.

About 13F filings

A Form 13F is a quarterly disclosure that institutional investment managers with over $100 million in US-listed equities must file with the SEC. In plain English: it is a snapshot of the long stock positions a fund held at the end of a quarter. It is filed up to 45 days after quarter-end, so it is backward-looking — the manager may have traded since — and it covers long US-listed equities only, not short positions, cash, or private holdings. Reading a 13F tells you what a manager owned, not whether you should own it.

Learn how to read a 13F

Explore other funds